ARTICLE | Company News
Amsterdam Molecular falls as CHMP rebuffs Glybera again
October 21, 2011 11:08 PM UTC
Amsterdam Molecular Therapeutics Holding N.V. (Euronext:AMT) fell EUR 0.40 (51%) to EUR 0.38 on Friday after EMA's CHMP issued a second negative opinion for Glybera to treat lipoprotein lipase (LPL) d...